Scorpius Holdings Overview
- Year Founded
-
2008
- Status
-
Public
- Employees
-
90
- Stock Symbol
-
SCPX
- Investments
-
2
Scorpius Holdings General Information
Description
Scorpius Holdings Inc is an integrated contract development and manufacturing organization (CDMO) focused on rapidly advancing biologic and cell therapy programs to the clinic and beyond. It offers a broad array of analytical testing, process development, and manufacturing services to pharmaceutical and biotech companies at its state of the art facilities.
Contact Information
Website
ir.scorpiusbiologics.comCorporate Office
- 627 Davis Drive
- Suite 300
- Morrisville, NC 27560
- United States
Corporate Office
- 627 Davis Drive
- Suite 300
- Morrisville, NC 27560
- United States
Scorpius Holdings Timeline
Scorpius Holdings Stock Performance
As of 17-Nov-2026, Scorpius Holdings’s current market cap is $12.2K with 61.1M shares.
(As of Tuesday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $12.2K | 61.1M | 14.7K | -$4.18 |
Scorpius Holdings Financials Summary
As of 30-Sep-2025, Scorpius Holdings has a trailing 12-month revenue of $1.72M.
|
In Thousands, USD |
TTM 30-Sep-2025 | FY 2024 31-Dec-2024 | FY 2023 31-Dec-2023 | FY 2022 31-Dec-2022 |
|---|---|---|---|---|
| EV | 15,975 | 7,510 | 15,676 | (29,538) |
| Revenue | 1,716 | 6,243 | 6,995 | 370 |
| EBITDA | (19,537) | (26,243) | (34,448) | (39,250) |
| Net Income | (25,181) | (32,808) | (45,217) | (43,435) |
| Total Assets | 20,771 | 39,178 | 51,038 | 104,397 |
| Total Debt | 18,117 | 28,549 | 14,042 | 9,299 |
Scorpius Holdings Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Scorpius Holdings Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price |
% Owned |
|---|
Scorpius Holdings Comparisons
Industry
Financing
Details
Scorpius Holdings Competitors (44)
One of Scorpius Holdings’s 44 competitors is Precigen, a Formerly VC-backed company based in Germantown, MD.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Precigen | Formerly VC-backed | Germantown, MD | ||||
| Vir Biotechnology | Formerly VC-backed | San Francisco, CA | ||||
| GT Biopharma | Corporation | San Francisco, CA | ||||
| Agenus | Formerly VC-backed | Lexington, MA | ||||
| ImmunityBio | Formerly VC-backed | San Diego, CA |
Scorpius Holdings Signals
Scorpius Holdings Acquisitions (2)
Scorpius Holdings’s most recent deal was a Merger/Acquisition with Elusys. The deal was made on 20-Apr-2022.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Elusys | 20-Apr-2022 | Merger/Acquisition | Biotechnology | ||
| Pelican Therapeutics | 28-Apr-2017 | Merger/Acquisition | Biotechnology |
Scorpius Holdings ESG
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
Rank
Percentile
Pharmaceuticals
Industry
Rank
Percentile
Biotechnology
Subindustry
Rank
Percentile
Scorpius Holdings Exits (1)
Scorpius Holdings’s most recent exit was on 20-Apr-2022 from Elusys. The exit was categorized as .
| Company Name | Exit Date | Exit Type | Exit Size | Status | Buyers |
|---|---|---|---|---|---|
| Elusys | 20-Apr-2022 | Completed |
|
Scorpius Holdings Affiliates
Subsidiaries (1)
| Name | Industry | Location | Year Founded |
|---|---|---|---|
| Abacus Biotech | Morrisville, NC |
Scorpius Holdings FAQs
-
When was Scorpius Holdings founded?
Scorpius Holdings was founded in 2008.
-
Where is Scorpius Holdings headquartered?
Scorpius Holdings is headquartered in Morrisville, NC.
-
What is the size of Scorpius Holdings?
Scorpius Holdings has 90 total employees.
-
What industry is Scorpius Holdings in?
Scorpius Holdings’s primary industry is Holding Companies.
-
Is Scorpius Holdings a private or public company?
Scorpius Holdings is a Public company.
-
What is Scorpius Holdings’s stock symbol?
The ticker symbol for Scorpius Holdings is SCPX.
-
What is the current market cap of Scorpius Holdings?
The current market capitalization of Scorpius Holdings is $12.2K.
-
What is Scorpius Holdings’s current revenue?
The trailing twelve month revenue for Scorpius Holdings is $1.72M.
-
Who are Scorpius Holdings’s competitors?
Precigen, Vir Biotechnology, GT Biopharma, Agenus, and ImmunityBio are some of the 44 competitors of Scorpius Holdings.
-
What is Scorpius Holdings’s annual earnings per share (EPS)?
Scorpius Holdings’s EPS for 12 months was -$4.18.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process